Soleno Therapeutics (SLNO) Interest & Investment Income (2017)
Historic Interest & Investment Income for Soleno Therapeutics (SLNO) over the last 3 years, with Q3 2017 value amounting to $4000.0.
- Soleno Therapeutics' Interest & Investment Income changed N/A to $4000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $8000.0, marking a year-over-year increase of 931176.47%. This contributed to the annual value of $12.1 million for FY2024, which is 36749.42% up from last year.
- According to the latest figures from Q3 2017, Soleno Therapeutics' Interest & Investment Income is $4000.0.
- In the past 5 years, Soleno Therapeutics' Interest & Investment Income ranged from a high of $4000.0 in Q3 2017 and a low of $85.0 during Q4 2014
- In the last 3 years, Soleno Therapeutics' Interest & Investment Income had a median value of $1000.0 in 2017 and averaged $1771.4.
- The largest annual percentage gain for Soleno Therapeutics' Interest & Investment Income in the last 5 years was 8898.96% (2014), contrasted with its biggest fall of 8898.96% (2014).
- Soleno Therapeutics' Interest & Investment Income (Quarter) stood at $772.0 in 2013, then crashed by 88.99% to $85.0 in 2014, then surged by 4605.88% to $4000.0 in 2017.
- Its Interest & Investment Income was $4000.0 in Q3 2017, compared to $3000.0 in Q2 2017 and $1000.0 in Q1 2017.